Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from PD-L1 inhibition in women with early triple-negative breast cancer - Sinn, Bruno; Loibl, Sibylle; Hanusch, Claus A.; Zahm, Dirk-Michael; Sinn, Peter; Untch, Michael; Weber, Karsten; Karn, Thomas; Becker, Clemens; Marmé, Frederik; Schmitt, Wolfgang D.; Müller, Volkmar; et al. (Clinical cancer research, 2021)
Gesehen am 14.07.2021